Umbilical cord mesenchymal stem cell therapy (Shanghai Life Science & Technology)

人脐带间充质干细胞（上海莱馥生命科学技术）

Report date: 2026/05/12 20:00:17

Base Information

Drug NameUmbilical cord mesenchymal stem cell therapy (Shanghai Life Science & Technology)
Drug Alias NameUC-MSC Transplantation
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsVentricular Dysfunction, LeftMyocardial InfarctionIdiopathic Pulmonary Fibrosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Life Science & Technology
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Life Science & TechnologyShanghai Laifu Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic ObstructiveLung Diseases, Interstitial
Inactive IndicationsVentricular Dysfunction, LeftMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A